Second Alzheimer's drug can slow disease by a few months
Another experimental Alzheimer's drug can modestly slow patients' inevitable worsening — by about four to seven months, researchers reported Monday.
Stay updated with breaking news from Mark Mintun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Another experimental Alzheimer's drug can modestly slow patients' inevitable worsening — by about four to seven months, researchers reported Monday.
Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.
EXCLUSIVE: A new drug has been shown to slow the rate at which memory and thinking skills decline.
The Pharmaceutical Journal from the Royal Pharmaceutical Society
The phase 3 drug trial from Eli Lilly and Company indicated significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer's.